Jabloñski, M., Rivero, E., Rodriguez, M. S., Bruque, C. D., Aparicio, E., Bruzzone, A., . . . Luthy, I. A. (2020). Effect of paclitaxel in combination with the beta2 adrenergic agonist salbutamol on breast cancer MDA-MB-231 cell line growing in vivo: Mechanist of action. Web
Citación estilo ChicagoJabloñski, Martina, Ezequiel Rivero, María Sol Rodriguez, Carlos David Bruque, Evangelina Aparicio, Ariana Bruzzone, Cecilia Pérez Piñero, and Isabel Alicia Luthy. Effect of Paclitaxel in Combination With the Beta2 Adrenergic Agonist Salbutamol On Breast Cancer MDA-MB-231 Cell Line Growing in Vivo: Mechanist of Action. 2020.
Cita MLAJabloñski, Martina, et al. Effect of Paclitaxel in Combination With the Beta2 Adrenergic Agonist Salbutamol On Breast Cancer MDA-MB-231 Cell Line Growing in Vivo: Mechanist of Action. 2020.